12/30/2025

Law Firm Cleary Gottlieb Hires Alsheimer for Activism Practice

Reuters (12/30/25) Herbst-Bayliss, Svea

International law firm Cleary Gottlieb Steen & Hamilton has hired an industry veteran to lead its shareholder activism defense practice as more law firms build out capabilities to protect clients facing corporate agitators. Sebastian Alsheimer is moving to Cleary as a partner from Wilson Sonsini Goodrich & Rosati, where he was also a partner, two sources familiar with the move said. He will be based in New York and will start in January. At Cleary, Alsheimer will advise the firm's corporate clients, including 3M (MMM), Honeywell (HON), and BlackRock (BLK) on engaging with activist investors as shareholder engagement and activism defense have increasingly become big business for law firms and banks. By hiring Alsheimer, Cleary is adding a partner who has represented companies battling corporate agitators and worked with activist investors planning corporate campaigns. He spent three years at Wilson Sonsini defending clients such as software design company Autodesk (ADSK) and financial software company BlackLine (BL) against Starboard Value and others. Before that, as a partner at Olshan Frome Wolosky, a firm that traditionally represents hedge funds, he worked with Elliott Investment Management and Starboard. Cleary is the latest blue-chip law firm to beef up its capabilities in countering investors pushing for changes, ranging from refreshing the boards of directors to selling companies. Earlier this year, Sullivan & Cromwell hired two partners from Vinson & Elkins; Paul, Weiss, Rifkind, Wharton & Garrison hired from Wachtell, Lipton, Rosen & Katz; and White & Case hired from Cadwalader, Wickersham & Taft. Simpson Thacher & Bartlett recently hired from a bank, adding the former head of shareholder advisory for the Americas at Barclays Capital. Alsheimer ranks among a small group of lawyers who specialize in activism defense that includes Sidley Austin's Kai Liekefett, Kirkland & Ellis' Shaun Mathew and Sullivan & Cromwell's Lawrence Elbaum.

Read the article

12/30/2025

Emboldened Activist Investors Are Circling US Banks

Wall Street Journal (12/30/25) Heeb, Gina

A relatively unknown hedge fund pushed Comerica (CMA) to sell itself this summer, pressuring the Texas-based lender to strike the biggest bank deal of 2025. That was just the start. It turns out HoldCo Asset Management didn’t like that particular deal, arguing it undervalued Comerica. Its battle with the bank has since turned into an all-out war. The firm urged shareholders to vote against Fifth Third Bancorp’s (FITB) acquisition of Comerica and sued the banks, saying it wasn’t the best option for shareholders. Comerica said in a statement it was committed to the deal. Fifth Third’s chief executive has said the bank is confident the transaction will close in early 2026. HoldCo has also agitated for change at KeyCorp (KEY) and several other regional banks, and co-founders Vik Ghei and Misha Zaitzeff are on the hunt for more targets. Their message is often to address underperformance or sell. “I would be shocked if there weren’t more Comericas,” Ghei said in an interview with The Wall Street Journal. Bank management teams and boards have long been “complacent, and I would even argue arrogant.” A new wave of activists has circled the gates of bankland, where major campaigns had historically been few and far between, in part because of heavy regulation. Now the Trump administration’s moves to ease rules around bank deals and capital requirements could give activists more room to play. Bank deals have started to rebound as all but the biggest players struggle under the weight of regulatory, technological and other costs. Lenders are also contending with new threats, including fintechs, cryptocurrencies and the growth of private markets. As of early December, bank-deal activity by value for the year had risen to the highest level since 2021, according to S&P Global Market Intelligence. Nathan Stovall, director of financial-institutions research at S&P Global Market Intelligence, said it is an unusual moment for activism in the banking industry. “You just haven’t seen campaigns like this,” he said. With $2.6 billion in assets under management, HoldCo is a bank-focused fund whose brazen approach has clashed with many in the tightknit industry. Recently, it has been shunned by some executives and barred from some industry conferences, according to Ghei and Zaitzeff. Others on Wall Street have looked to ramp up pressure on banks, too. Before Comerica agreed to sell, equity analysts publicly pressed the bank about underperformance and how it justified its independence. Other activist investors that typically target other industries have also started to look at banks, encouraged by HoldCo’s recent momentum, according to Jason Blumberg, founder of bank investment and advisory firm Blue Hill Advisors. Some of those investors have reached out to him to inquire about investments through his firm or joint ventures, he said. “Now is the time,” said Blumberg, who was previously at HoldCo. “2026 could be a big year.” Banks have looked to batten down the hatches in response. Some have started to review bylaws, looked to adopt rights plans or stayed in closer communication with major shareholders, according to people familiar with the matter. Others have hit the pause button on deal considerations because of fear of how activists would respond, some of the people said. In its recent presentation to the KeyCorp board of directors, HoldCo said the bank should swear off acquisitions and instead buy back stock. KeyCorp CEO Chris Gorman backed such plans at an industry conference shortly after. “We and that particular investor are pretty closely aligned on the most important themes,” he said. Activists still face an uphill battle at banks. Lenders often have a special status as stewards of deposits, often with unique ties to customers, shareholders and the government. At smaller banks, for example, boards and management teams are often made up of loyal community members. Proxy advisory firm Institutional Shareholder Services recently said HoldCo “deserves credit for its campaign” at Comerica. But ISS recommended shareholders vote to approve the acquisition by Fifth Third. The vote is set to take place in early January.

Read the article

12/30/2025

Key Sale, Acquisition Helped Solventum Turn Around in 2025

The Minnesota Star Tribune (12/30/25) Stefanescu, Victor

Solventum (SOLV), a 3M (MMM) spinoff based in Maplewood, is a medical supplies giant and Minnesota's newest Fortune 500 company. 3M is partnering with companies around the globe, and working in a lab in Maplewood, to develop solutions for hydrogen, seen as a promising though still expensive clean energy source. The 3M spinoff commenced 2025 with a deflated stock, which incurred concerns about the health care company’s direction from one of its largest shareholders. Nearly a year and a few key business decisions later, the medical supplies giant is attracting renewed investor interest with a revamped innovation process and a slimmer portfolio aimed at efficiency. Now Solventum must continue this upward trajectory to establish itself as another Minnesota public company with longstanding success. In a Dec. 16 letter filed with the Securities and Exchange Commission, CEO Bryan Hanson said the company’s pace of execution “has been purposeful and intense, fueling optimism for 2026 and beyond.” At the time of Hanson’s letter, the company’s stock had pivoted up by more than 20% in 2025. Heather Knight, Solventum’s chief commercial officer appointed this fall, said it appears the market is recognizing the company’s transformation. “I think they like the capital-allocation strategy that we’re bringing forward,” Knight said. “And you can only really do that when you have strong financial performance, a really good balance sheet and cash-flow generation.” In January, the tone around Solventum was different. Trian Partners, billionaire Nelson Peltz’s investment management firm, labeled Solventum’s performance as “alarming” in a letter assessing the company’s trajectory. The firm had amassed a nearly 5% stake in Solventum, becoming one of its largest shareholders. “Many current and prospective shareholders have expressed concern to us that the company has set extremely low expectations for the business today and a disappointing vision for the future,” the letter read. Trian declined to comment further. But its complaints partly date back to an initial investor conference prior to Solventum’s listing on the New York Stock Exchange on April 1, 2024. Solventum hosted one of “the more unusual pre-spin investor days” on March 19, the activist’s letter said, an event that highlighted more of the troubles ahead than the opportunities. While Hanson said at the conference that he “absolutely” saw a pathway to unlocking “significant value creation” with Solventum, he also preached caution. He told investors the company would face challenges and suggested they think of the spinoff in terms of years, not months. Under 3M, Hanson said at the conference, Solventum wasn’t focused on the right performance metrics, and its market growth lagged behind peers. It was a hierarchical environment, with executives at the top making all the decisions and forcing business unit leaders to compete for resources. “We’re just trying to do too much. We’re not focused,” Hanson said then, adding that the spinoff would be “distracting for everybody” as it created billions in debt. Solventum and 3M were more entangled than Hanson had expected. The company’s share price stayed flat until October, underperforming competitors. By December 2024, a broad restructuring shifted the way the company operated and led to job losses. Yet about a calendar year later to the end of 2025, the company has appeared to chart a turnaround.

Read the article

12/30/2025

Lululemon Responds to Founder’s Proxy Fight Moves

SGB Media (12/30/25)

In response to Lululemon Athletica’s (LULU) founder, Chip Wilson, announcing that he has submitted a notice to nominate three director candidates, Lululemon defended the experience of its Board, its CEO succession process, and the retailer’s performance since Wilson stepped down from the board in 2015. Lululemon also reported it will evaluate Wilson’s board nominees “in due course in accordance with the Board’s governance process.” The nominees, who will be put to shareholders at Lululemon’s 2026 Annual Meeting, are Marc Maurer, former co-chief executive of On Holding; Laura Gentile, former chief marketing officer of ESPN; and Eric Hirshberg, former chief executive of video game publisher Activision. Wilson has also submitted a non-binding shareholder proposal seeking to declassify the Board, a move that would require all directors to stand for election annually rather than on a staggered basis. The developments come weeks after Lululemon confirmed that its Chief Executive, Calvin McDonald, will step down on January 31, 2026. Lululemon’s full statement reads as follows: “The Lululemon Board of Directors and leadership team have engaged extensively and in good faith for many years with Mr. Wilson to understand his perspectives and communicate our strategy. In our most recent discussions, Mr. Wilson indicated his intent to nominate directors. In the interest of avoiding a costly and distracting proxy fight, the Board requested from Mr. Wilson the names of his director nominees to evaluate their qualifications and backgrounds, but Mr. Wilson declined to engage further. Now that the names have been submitted, the Board will evaluate Mr. Wilson’s director nominees in due course in accordance with the Board’s governance process. Lululemon has a highly engaged and experienced Board that is well-equipped to provide effective guidance on the company’s direction and the execution of our growth strategy. Over one-third of our directors have joined the Board within the past four years. Our Board and leadership team are focused on driving long-term, sustainable growth and shareholder value creation. Over the last 10 years, the Board has overseen a significant period of growth, with revenues increasing nearly $9 billion, from $2.1 billion in fiscal year 2015 to $11.0 billion expected in fiscal year 2025 based on our guidance. Over the same time period, income from operations will have grown by nearly 6x. These results have generated significant cash flow that has enabled the company to make substantial investments in the business for growth and to return capital to shareholders through cumulative share repurchases in excess of $5.5 billion since fiscal 2015. We are encouraged by the strength we are seeing internationally and the work underway in the U.S., but we recognize that further opportunities exist to realize greater value across the company. To help achieve this goal, the Board has initiated a comprehensive search for the company’s next CEO. The Board is focused on identifying a leader with a track record of guiding companies through periods of growth and transformation who can build on our strong foundation and bring fresh perspectives to our brand strategy. Mr. Wilson has not been involved with the company for a decade, and since his departure, Lululemon has continued to adapt to the marketplace and lead the industry, building one of the most compelling growth stories in retail. The Lululemon Board of Directors will continue to take actions that we believe are in the best interests of all the company’s shareholders. Lululemon shareholders do not need to take any action at this time. The Board will review and consider Mr. Wilson’s director candidate nominations and present a formal recommendation regarding his nominations in the company’s definitive proxy statement in advance of the company’s 2026 Annual Meeting of Shareholders. J.P. Morgan is acting as financial advisor to Lululemon, and Sidley Austin LLP is serving as legal advisor. Joele Frank, Wilkinson Brimmer Katcher is serving as strategic communications advisor to Lululemon.”

Read the article

12/29/2025

Swiss Asset Manager GAM Opposes Takeover of Honda Unit by India’s Motherson

Wall Street Journal (12/29/25) Narioka, Kosaku

Swiss asset manager GAM Holding (GAM) is opposing a planned takeover of a Honda (7267) subsidiary by Indian auto-parts maker Samvardhana Motherson International (MOTHERSON), saying the deal significantly undervalues the Japanese company. GAM Chief Executive Albert Saporta said the asset manager sent a letter to the president of auto-parts maker Yutaka Giken, urging the Honda unit to either abandon the transaction or seek a significantly higher price. Samvardhana Motherson said in late August that it planned to acquire an 81% stake in Yutaka Giken for about 27 billion yen, equivalent to $172.4 million. As part of the deal, Samvardhana Motherson plans to start a tender offer to buy Yutaka shares for 3,024 yen each from minority shareholders, valuing the company at about 45 billion yen. Hamamatsu-based Yutaka is a profitable, cash-rich company and makes parts used in exhaust systems, drive systems, brake discs and heat-management devices. It had about 104 billion yen in net assets as of the end of September, with equity at 61% of assets. Saporta said that the tender offer price should be at least 50%-70% higher than the current offered price and that the deal is a big step backward for Japan’s recent efforts to improve corporate governance. Saporta said that GAM funds held shares in Yutaka Giken since before Samvardhana Motherson announced its tender offer plan and that GAM isn’t opposed to the sale of Yutaka Giken itself. He said the acquisition of Yutaka could enable Samvardhana Motherson to realize significant synergies and additional revenue opportunities. A number of Japanese companies in recent years have taken full control of listed units and affiliates or sold them as the Japanese government has pressed them for higher capital efficiency and better corporate governance. That created waves of acquisitions in Japan by domestic and foreign investors.

Read the article

12/29/2025

Lululemon Founder Chip Wilson Launches Proxy Fight to Change Board

Wall Street Journal (12/29/25) Thomas, Lauren

Lululemon Athletica (LULU) founder Chip Wilson is launching a proxy fight at the athletic-apparel retailer in an effort to remake the company’s board while Lululemon searches for a new chief executive. Wilson said Monday that he has nominated three director candidates to the company’s board. The nominees are former On Running co-CEO Marc Maurer, former ESPN Chief Marketing Officer Laura Gentile, and former Activision CEO Eric Hirshberg. Wilson isn’t trying to put himself back on the board, which might come as a surprise to some given his recent efforts to publicly target the company he started. He remains Lululemon’s second-biggest shareholder, with a nearly 9% stake, according to FactSet. (Vanguard is the largest holder.) “I know this campaign for change cannot be about me,” Wilson said. “It is about recommitting Lululemon to genuine creative leadership that will re-establish a brand of enduring strength.” Activist investors often tap former company executives to help them shake up targets, but it is rare to see a founder of a company turning to a hostile approach such as a board fight. Lululemon is in the midst of an identity crisis and earlier this month said that its CEO, Calvin McDonald, will step down in January. Its stock is down 45% this year, while the broader market has rallied. Pressure had been mounting for McDonald to turn around the business, including from Wilson, who had been publicly criticizing him and the company for killing innovation and “losing its cool.” Sales have recently stagnated in the U.S., with newer rivals such as Alo Yoga and Vuori eating at market share. The Journal previously reported that Wilson had tapped financial advisers and was considering waging a proxy battle before Lululemon’s nomination window closes at the end of this month. Maurer, who stepped down as On Running co-CEO at the end of June, helped build a leading sportswear brand. Gentile founded ESPNW, ESPN’s brand dedicated to women. And Hirshberg oversaw top franchises including “Call of Duty” during his time at Activision, the largest segment of Activision Blizzard. Wilson isn’t the only one pushing for change. Elliott Investment Management has built a stake of more than $1 billion in Lululemon and is advocating for former Ralph Lauren executive Jane Nielsen to be the next CEO, the Journal reported last week. Wilson has spoken to Nielsen, people familiar with the matter said. The founder said Monday that while he understands the urgency to find a new CEO, he believes Lululemon shareholders won’t trust any CEO who is picked by the current board so wants to change the board first. “Shareholders have no faith that this board can select and support the next CEO without input from a board with stronger product experience,” Wilson said. Wilson found his inspiration to start Lululemon in Vancouver, British Columbia, after attending a yoga class during the late 1990s. The $100 sweat-wicking leggings quickly developed a cultlike following among women who would wear them everywhere—from workouts to the grocery store. He stepped aside as CEO in 2005, when he sold 48% of Lululemon to private-equity firm Advent International. Lululemon went public in 2007 at a valuation of more than $1.2 billion. Advent has since sold out of its stake, though the firm still has a board seat. Wilson remained chairman and held other roles at the retailer in the ensuing years. Controversial comments around quality control that he made in a 2013 television interview led him to apologize and step down from his chairman position later that year. Wilson left Lululemon’s board entirely in 2015, later saying that he chose to leave because he didn’t feel that he could speak up against management. Four Lululemon CEOs have cycled through since Wilson left the job. By the time he departed, Lululemon had nearly 300 retail stores around the world. Wilson’s experience building brands has led him to other opportunities in retail. In 2019, he was part of a consortium that bought Amer, whose brands include Salomon and Arc’teryx. The company went public last year and its stock is up more than 35% this year, with a market value of over $21 billion.

Read the article

12/29/2025

Sanofi Lays Out $2.2B for Hepatitis Vaccine Maker Dynavax

Fierce Pharma (12/29/25) Kansteiner, Fraiser

Following a feud with Deep Track Capital in the first half of 2025, vaccine developer Dynavax Technologies (DVAX) has rounded out the year by agreeing to sell itself to France’s Sanofi. To get its hands on the Emeryville, California-based company and its approved adult hepatitis B vaccine Heplisav-B, Sanofi will pay $15.50 per Dynavax share in cash, which works out to a total deal value of roughly $2.2 billion, the French pharma said in a Dec. 24 press release. The acquisition, which is expected to close in 2026’s first quarter, also grants Sanofi access to Dynavax’s promising shingles prophylactic Z-1018, which is currently in phase 1/2 testing and could eventually challenge GSK’s incumbent shot Shingrix, if approved. The addition of Dynavax’s hepatitis vaccine Heplisav-B is expected to help round out Sanofi’s armamentarium of approved adult immunizations, which has traditionally leaned heavily on the drugmaker’s roster of influenza shots. In 2025’s third quarter, Sanofi reported that its overall vaccine sales had slipped nearly 8% to 3.4 billion euros, which the company blamed in October on “lower influenza sales.” Given that Heplisav-B is indicated for adults, Dynavax’s commercial vaccine won’t be affected by the recent vote from the CDC’s Advisory Committee on Immunization Practices (ACIP) to remove a recommendation for universal hepatitis B vaccination for infants at birth in the U.S. The buyout comes amid broader shifts in vaccination trends and policy in the U.S., especially for children, under a Department of Health and Human Services (HHS) led by noted vaccine skeptic Robert F. Kennedy Jr. Dynavax has accepted Sanofi’s offer in the wake of a contentious battle with activist investor Deep Track Capital earlier in 2025. Back in February, Deep Track intensified demands for Dynavax to refocus its efforts on its lone approved product, Heplisav, and forego what the investor called a “misguided empire-building exercise” of pursuing external asset acquisitions. At the time, Deep Track estimated that the nearly eight-year-old vaccine Heplisav could generate more than $1 billion through 2030. A key part of Deep Track’s plan was to instill four of its own picks to Dynavax’s board. But Dynavax held its ground and ultimately prevailed at its annual meeting in June, re-electing all four of its own candidates and defeating Deep Track’s attempts to unseat the directors, Reuters reported over the summer.

Read the article

12/29/2025

AEP Reaches Agreement with Icahn Group, Announces Board and Bylaw Changes

Investing.com (12/29/25)

American Electric Power Company, Inc. (AEP), a utility giant with a market capitalization of $61.78 billion and a P/E ratio of 16.9, announced Monday that it has entered into a Board Observer Agreement with Carl Icahn and affiliated entities, known collectively as the Icahn Group, and Andrew J. Teno. Under the agreement, Mr. Teno will serve as a non-voting observer to the company’s Board of Directors. As part of the Board Observer Agreement, the Icahn Group has agreed to certain standstill and mutual non-disparagement provisions. The agreement can be terminated by either party at any time with notice. Following the execution of the new agreement, American Electric Power and the Icahn Group have agreed to terminate the Director Appointment and Nomination Agreement, which was originally put in place on February 12, 2024. The termination became effective December 22, 2025. In a separate development, the company’s Board of Directors approved changes on December 2, 2025, to its committee structure, effective July 1, 2026. The number of active board committees will be reduced from seven to five. The Finance Committee will be eliminated, with its responsibilities distributed between the full Board and the Audit Committee. Additionally, the Nominating and Governance Committee will be combined with the Human Resources Committee, and the merged committee will be renamed the Nomination, Governance & Compensation Committee. On December 22, 2025, the Board also adopted amendments to the company’s bylaws, effective July 1, 2026, to reflect the new name for the committee. American Electric Power stated that further details of the Board Observer Agreement and amended bylaws will be included as exhibits in upcoming filings. This information is based on a statement released in an SEC filing.

Read the article

12/26/2025

Pressure Grows on Target as Activist Investor Builds Stake

Financial Times (12/26/25) Barnes, Oliver; Meyer, Gregory

US retail chain Target (TGT) is facing pressure from an activist investor after a sales slump that has wiped out nearly a third of its share value this year, according to people familiar with the details. Toms Capital Investment Management (TCIM), a US hedge fund that built a stake in Tylenol maker Kenvue (KVUE) before its $48.7 billion sale to Kimberly-Clark (KMB) last month, has made a significant investment in Target, the people said. The exact size of TCIM’s stake is unknown. Target had a $43.7 billion market capitalization as of Wednesday’s close. The pressure comes after Target in November reported its 12th consecutive quarter of negative or negligible sales growth. Target’s share price is down 64% from its all-time high during the Covid-19 pandemic, when customers flocked to it as a one-stop shop for necessities, clothes and home goods. It has underperformed the wider retail sector. TCIM declined to comment. Founded by alumni of London-based hedge fund GLG Partners in 2017, it has recently built stakes and pushed for strategic changes at Pringles maker Kellanova, US Steel, and Kenvue. Target said in a statement that it maintained a “regular dialogue” with all of its shareholders. “Target’s top priority is getting back to growth, and our strategy to do so is rooted in three strategic priorities: leading with merchandising authority, providing a consistently elevated shopping experience and leveraging technology,” the company said. “We are confident the execution of this plan will drive the business forward and deliver sustained, long-term value for shareholders.” Target’s longtime Chief Executive Brian Cornell plans to step down in February after more than a decade in the top job. He is being replaced by chief operating officer Michael Fiddelke, who after 23 years at the retailer has been tasked with orchestrating a major overhaul. Fiddelke told investors last month that Target would spend $5 billion in 2026, roughly $1 billion more than this year, on improvements such as store renovations, product refreshes and a better digital experience. “We are not satisfied with our current results and are relentless in our pursuit of returning to growth,” he said on November’s investor call. Analysts have highlighted Target’s advantages: 75% of the U.S. population live within 10 miles of its nearly 2,000 stores, second only to Walmart, and it owns 78% of its stores. A recent UBS analyst report noted how Target could monetize its real estate in a similar way to US farm supply retailer Tractor Supply (TSCO). Yet consumers have become more cautious about spending, and Target, which relies more on discretionary goods such as decor, has been hit harder than rivals. Walmart’s share price is close to a record high, giving it a market capitalization of almost $900 billion, while the share price of warehouse club store Costco has more than doubled over the past five years. In October, Target cut 1,000 roles and a further 800 open positions at its headquarters in Minneapolis, Minnesota. The job losses accounted for about 8% of its 22,000 corporate employees. With about half of its merchandise sourced from outside the US — China is its main source of imported products — it has been hit by US President Donald Trump’s sweeping tariffs. While the tariffs have increased the cost of merchandise, Target lowered prices for 3,000 household essentials during the holiday shopping season.

Read the article